IBM is the world’s top supplier in computer hardware, the largest provider of technology services, the second largest provider in software, and a leader in semi-conductor manufacturing.
GoalProviding comprehensive treatment to employees, thereby reducing HIV/AIDS-related expenses by 40% if the programme is successful.
Key questions
- Can a company provide HIV/AIDS benefits to HIV-positive employees outside the medical aid scheme?
- How does having an employee co-pay for treatment services affect treatment -seeking behaviour?
- Can companies in countries with a much lower HIV prevalence use this approach to treat their employees?
Programme description
IBM South Africa’s programme focuses on prevention through access to self-serve HIV/AIDS education through interactive software and treatment including Highly Active Anti-Retroviral Therapy (HAART).
- Management approved IBM South Africa’s HIV/AIDS policy on 1 October 2001. The policy was revised in early 2003. The policy was developed by the human resources department in consultation with other companies with existing workplace policies. Human Resources worked to ensure that the policy was compliant with all relevant legislation.
- In addition to annual events, condom distribution, and STI treatment, IBM South Africa’s awareness campaigns focus on providing self-service interactive software to raise employee knowledge and awareness.
- VCT has been available through IBM South Africa’s Medical Centre since the early 1980’s.
HIV-positive employees gain access to IBM South Africa’s treatment programme, including access to Highly Active Anti-Retroviral Treatment (HAART).
Click here to view the full report.
Click here to view IBM’s HIV/AIDS POLICY.
|